Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.10%19.7014.1%$436.29m
SAGESAGE Therapeutics, Inc.
2.72%162.3210.9%$216.91m
SHPGShire PLC Sponsored ADR
2.77%151.270.4%$168.46m
PRGOPerrigo Co. Plc
2.93%86.506.6%$88.44m
MNKMallinckrodt Plc
1.08%23.3618.5%$79.35m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.47%130.217.6%$59.41m
UTHRUnited Therapeutics Corporation
1.20%137.4114.5%$56.06m
JAZZJazz Pharmaceuticals Plc
0.02%135.532.2%$56.04m
ICPTIntercept Pharmaceuticals, Inc.
0.02%61.6222.0%$40.25m
RVNCRevance Therapeutics, Inc.
-0.31%32.0512.2%$36.88m
CTLTCatalent Inc
2.65%41.122.6%$36.60m
MDCOMedicines Company
0.18%27.3022.1%$36.53m
ADMSAdamas Pharmaceuticals, Inc.
1.56%32.5816.9%$36.42m
ENDPEndo International Plc
2.43%8.008.9%$33.43m
PTLAPortola Pharmaceuticals, Inc.
-1.12%47.027.8%$33.19m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. The company's products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.